This activity, supported by Eli Lilly and Company in collaboration with SPCC, was designed to bring together healthcare professionals and innovative organizations to identify gaps in the treatment of Early Breast Cancer and develop strategies to improve care and address those gaps. The initiative aimed to facilitate the involvement of patients, caregivers, and families in collaborative decision-making processes, while also employing evidence-based educational strategies aligned with the desired outcomes of the intervention.